{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:47:40Z","timestamp":1780440460090,"version":"3.54.1"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Retention in buprenorphine therapy is associated with a lower risk of opioid overdose. Nevertheless, many patients discontinue treatment, and there is limited evidence to guide buprenorphine tapering.<\/jats:p><\/jats:sec>Objective<\/jats:title>To understand what prescribing characteristics are associated with opioid overdose following buprenorphine taper.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This is a population-based, retrospective, cohort study of adults who were maintained on buprenorphine for at least 60 days and underwent a buprenorphine taper. The study was conducted in the Canadian province of Ontario, using linked administrative health data. New buprenorphine treatment episodes were accrued between January 1, 2013, and January 1, 2019, and the maximum follow-up was April 30, 2020. Data analysis was performed from December 2020 to August 2022.<\/jats:p><\/jats:sec>Exposures<\/jats:title>The primary exposure of interest was time to taper initiation (\u22641 year vs &amp;gt;1 year). Secondary exposures included mean rate of taper, percentage days during which the dose was decreasing, and taper duration.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome measure was time to fatal or nonfatal opioid overdose within 18 months following treatment discontinuation.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 5774 individuals, the median (IQR) age at index date was 34 (28-44) years, and 3462 individuals (60.0%) were male. Time to taper initiation longer than 1 year vs 1 year or less (6.73 vs 10.35 overdoses per 100 person-years; adjusted hazard ratio [aHR], 0.69; 95% CI, 0.48-0.997), a lower mean rate of taper (\u22642 mg per month, 6.95 overdoses per 100 person-years; &amp;gt;2 to \u22644 mg per month, 11.48 overdoses per 100 person-years; &amp;gt;4 mg per month, 17.27 overdoses per 100 person-years; \u22642 mg per month vs &amp;gt;4 mg per month, aHR, 0.65; 95% CI, 0.46-0.91; &amp;gt;2 to \u22644 mg per month vs &amp;gt;4 mg per month, aHR, 0.69; 95% CI, 0.51-0.93), and dose decreases in 1.75% or less of days vs more than 3.50% of days during the taper period (5.87 vs 13.87 overdoses per 100 person-years; aHR, 0.64; 95% CI, 0.43-0.93) were associated with reduced risk of opioid overdose; however, taper duration was not.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this retrospective cohort study, buprenorphine tapers undertaken after at least 1 year of therapy, a slower rate of taper, and a lower percentage of days during which the dose was decreasing were associated with a significantly lower risk of opioid overdose, regardless of taper duration. These findings underscore the importance of a carefully planned taper and could contribute to reduction in opioid-related overdose death.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.34168","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T15:32:43Z","timestamp":1664465563000},"page":"e2234168","source":"Crossref","is-referenced-by-count":11,"title":["Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper"],"prefix":"10.1001","volume":"5","author":[{"given":"Nikki","family":"Bozinoff","sequence":"first","affiliation":[{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Men","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kurdyak","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Ontario, Canada"},{"name":"Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Selby","sequence":"additional","affiliation":[{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Ontario, Canada"},{"name":"Li Ka Shing Knowledge Institute, St Michael\u2019s Hospital, Toronto, Ontario, Canada"},{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"zoi220970r3","doi-asserted-by":"publisher","first-page":"c5475","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database.","volume":"341","author":"Cornish","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"zoi220970r4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/add.2011.106.issue-1","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies.","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"issue":"9","key":"zoi220970r5","doi-asserted-by":"publisher","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline.","volume":"190","author":"Bruneau","year":"2018","journal-title":"CMAJ"},{"issue":"3","key":"zoi220970r7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/002204268401400307","article-title":"Always a junkie? the arduous task of getting off methadone maintenance.","volume":"14","author":"Rosenbaum","year":"1984","journal-title":"J Drug Issues"},{"key":"zoi220970r8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.drugalcdep.2018.05.010","article-title":"Tapering off and returning to buprenorphine maintenance in a primary care office based addiction treatment (OBAT) program.","volume":"189","author":"Weinstein","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"zoi220970r9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jsat.2015.04.002","article-title":"Patient perspectives associated with intended duration of buprenorphine maintenance therapy.","volume":"56","author":"Bentzley","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"12","key":"zoi220970r10","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Intern Med"},{"key":"zoi220970r11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jsat.2014.12.011","article-title":"Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes.","volume":"52","author":"Bentzley","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"2-3","key":"zoi220970r12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drugalcdep.2006.12.019","article-title":"Overdose after detoxification: a prospective study.","volume":"89","author":"Wines","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi220970r13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1176\/appi.ajp.2019.19060612","article-title":"Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder.","volume":"177","author":"Williams","year":"2020","journal-title":"Am J Psychiatry"},{"key":"zoi220970r14","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"zoi220970r15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/02791072.1996.10472486","article-title":"Improving detoxification outcomes from methadone maintenance treatment: the interrelationship of affective states and protracted withdrawal.","volume":"28","author":"Latowsky","year":"1996","journal-title":"J Psychoactive Drugs"},{"issue":"2","key":"zoi220970r16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/A:1005574918294","article-title":"Disciplining addictions: the bio-politics of methadone and heroin in the United States.","volume":"24","author":"Bourgois","year":"2000","journal-title":"Cult Med Psychiatry"},{"issue":"3","key":"zoi220970r17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/02791072.1991.10471586","article-title":"Staying off methadone maintenance.","volume":"23","author":"Rosenbaum","year":"1991","journal-title":"J Psychoactive Drugs"},{"issue":"1","key":"zoi220970r18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0740-5472(88)90037-2","article-title":"Tapering from methadone maintenance: attitudes of clients and staff.","volume":"5","author":"Gold","year":"1988","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"zoi220970r19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1108\/IJPH-02-2020-0012","article-title":"Punitive discontinuation of opioid agonist therapy during incarceration.","volume":"16","author":"Marmel","year":"2020","journal-title":"Int J Prison Health"},{"issue":"12","key":"zoi220970r21","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1001\/jama.1977.03270390032021","article-title":"Ability to remain abstinent after methadone detoxification: a six-year study.","volume":"237","author":"Stimmel","year":"1977","journal-title":"JAMA"},{"key":"zoi220970r22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/nyas.1981.362.issue-1","article-title":"Detoxification after methadone maintenance treatment.","volume":"362","author":"Cushman","year":"1981","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"zoi220970r23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0002-9343(78)90691-5","article-title":"Abstinence following detoxification and methadone maintenance treatment.","volume":"65","author":"Cushman","year":"1978","journal-title":"Am J Med"},{"issue":"3","key":"zoi220970r24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/00952997409011032","article-title":"Detoxification of rehabilitated methadone patients: frequency and predictors of long-term success.","volume":"1","author":"Cushman","year":"1974","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"24","key":"zoi220970r25","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1001\/jama.1976.03260500020019","article-title":"Successful detoxification from methadone maintenance: follow-up study of 38 patients.","volume":"235","author":"Riordan","year":"1976","journal-title":"JAMA"},{"issue":"10","key":"zoi220970r26","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3109\/10826089509105138","article-title":"Factors associated with successful withdrawal from methadone maintenance treatment in Sweden.","volume":"30","author":"Eklund","year":"1995","journal-title":"Int J Addict"},{"issue":"5","key":"zoi220970r27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3109\/10826089409047404","article-title":"Detoxification from methadone maintenance treatment in Sweden: long-term outcome and effects on quality of life and life situation.","volume":"29","author":"Eklund","year":"1994","journal-title":"Int J Addict"},{"issue":"6","key":"zoi220970r28","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3109\/10826087609058824","article-title":"Detoxification of long-term methadone patients: problems and prospects.","volume":"11","author":"Lowinson","year":"1976","journal-title":"Int J Addict"},{"issue":"9","key":"zoi220970r29","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1111\/j.1360-0443.2012.03870.x","article-title":"Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study.","volume":"107","author":"Nosyk","year":"2012","journal-title":"Addiction"},{"issue":"3","key":"zoi220970r31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jama.2019.18913","article-title":"Trends in buprenorphine treatment in the United States, 2009-2018.","volume":"323","author":"Olfson","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"zoi220970r34","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1503\/cmaj.090784","article-title":"Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.","volume":"181","author":"Dhalla","year":"2009","journal-title":"CMAJ"},{"issue":"12","key":"zoi220970r35","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.","volume":"68","author":"Weiss","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"zoi220970r36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108416","article-title":"Patterns of patient discontinuation from buprenorphine\/naloxone treatment for opioid use disorder: a study of a commercially insured population in Massachusetts.","volume":"131","author":"Hasan","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"zoi220970r37","doi-asserted-by":"publisher","first-page":"424.e1","DOI":"10.1016\/j.ajog.2021.04.210","article-title":"Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder.","volume":"225","author":"Schiff","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"zoi220970r38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bja.2019.12.006","article-title":"Evaluation of opioid discontinuation after non-orthopaedic surgery among chronic opioid users: a population-based cohort study.","volume":"124","author":"Jivraj","year":"2020","journal-title":"Br J Anaesth"},{"key":"zoi220970r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108799","article-title":"Characterizing opioid agonist treatment discontinuation trends in British Columbia, Canada, 2012-2018.","volume":"225","author":"Krebs","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi220970r40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/add.v116.1","article-title":"The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.","volume":"116","author":"Farnum","year":"2021","journal-title":"Addiction"},{"issue":"7","key":"zoi220970r41","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1007\/s11606-021-06969-1","article-title":"Telehealth utilization is associated with lower risk of discontinuation of buprenorphine: a retrospective cohort study of US veterans.","volume":"37","author":"Vakkalanka","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"6","key":"zoi220970r42","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"4","key":"zoi220970r44","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes: a large sample study.","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"issue":"2","key":"zoi220970r45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data.","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"6","key":"zoi220970r46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks.","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"zoi220970r47","doi-asserted-by":"publisher","first-page":"m772","DOI":"10.1136\/bmj.m772","article-title":"Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.","volume":"368","author":"Pearce","year":"2020","journal-title":"BMJ"},{"issue":"9","key":"zoi220970r48","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis.","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"zoi220970r49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/archpsyc.1977.01770150119014","article-title":"Withdrawal from methadone maintenance: rate of withdrawal and expectation.","volume":"34","author":"Senay","year":"1977","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"zoi220970r50","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1377\/hlthaff.2019.01085","article-title":"Impact of long-term buprenorphine treatment on adverse health care outcomes in Medicaid.","volume":"39","author":"Samples","year":"2020","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"zoi220970r51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/09595230500170241","article-title":"From opioid maintenance to abstinence: a literature review.","volume":"24","author":"Korn\u00f8r","year":"20051","journal-title":"Drug Alcohol Rev"},{"issue":"9","key":"zoi220970r52","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/j.1360-0443.2012.03936.x","article-title":"Commentary on Nosyk et?al. (2012): detoxification from methadone maintenance therapy: how important is the exact technique that is used?","volume":"107","author":"Day","year":"2012","journal-title":"Addiction"},{"issue":"7","key":"zoi220970r53","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/00005053-198807000-00003","article-title":"Methadone maintenance to abstinence: how many make it?","volume":"176","author":"Milby","year":"1988","journal-title":"J Nerv Ment Dis"},{"issue":"6","key":"zoi220970r54","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3109\/10826087309033105","article-title":"Voluntary detoxification of patients on methadone maintenance.","volume":"8","author":"Berger","year":"1973","journal-title":"Int J Addict"},{"key":"zoi220970r2","volume-title":"Provisional Drug Overdose Death Counts","author":"Ahmad","year":"2022"},{"key":"zoi220970r6","volume-title":"Medications for Opioid Use Disorder Save Lives","author":"Mancher","year":"2019"},{"key":"zoi220970r43","volume-title":"The John Hopkins ACG\u00ae Case-Mix System Version 6.0 Release Notes","author":"The John Hopkins University Bloomberg School of Public Health HSRDC","year":"2003"},{"key":"zoi220970r1","unstructured":"Government of Canada. Opioid and stimulant-related harms in Canada. 2021. Accessed March 7, 2022. https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants"},{"key":"zoi220970r20","unstructured":"Rush? B, Talbot? A, Ali? F, . Environmental scan of withdrawal management practices and services in Canada: response to opioid use disorder. June 2021. Accessed August 26, 2022. http:\/\/crismontario.ca\/SiteAssets\/WMS%20Report.June2021.pdf"},{"key":"zoi220970r30","unstructured":"American Society of Addiction Medicine. The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update. December 18, 2019. Accessed August 29, 2022. https:\/\/sitefinitystorage.blob.core.windows.net\/sitefinity-production-blobs\/docs\/default-source\/guidelines\/npg-jam-supplement.pdf?sfvrsn=a00a52c2_2"},{"key":"zoi220970r32","unstructured":"The Ontario Drug Policy Research Network. Ontario prescription opioid tool. 2020. Accessed November 2, 2020. https:\/\/odprn.ca\/ontario-opioid-drug-observatory\/ontario-prescription-opioid-tool\/trends\/"},{"key":"zoi220970r33","unstructured":"Ontario Ministry of Health and Long-term Care. Monitored drugs list. March 29, 2021. Accessed April 28, 2021. https:\/\/www.health.gov.on.ca\/en\/pro\/programs\/drugs\/monitored_productlist.aspx"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2796830\/bozinoff_2022_oi_220970_1663855675.72656.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T15:32:54Z","timestamp":1664465574000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2796830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.34168","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}